• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis.

作者信息

Johnston A L, Thevos A K, Randall C L, Anton R F

机构信息

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston.

出版信息

Br J Addict. 1991 Jun;86(6):719-25. doi: 10.1111/j.1360-0443.1991.tb03098.x.

DOI:10.1111/j.1360-0443.1991.tb03098.x
PMID:1878622
Abstract

The purpose of this study was to determine whether alcoholics with a co-existing anxiety disorder (dual-diagnosed group) experienced different withdrawal symptomatology from alcoholics without an anxiety disorder (alcohol-only group). Symptoms of alcohol withdrawal were measured on admission to an in-patient treatment program and throughout treatment (days 0, 2, 7, 14 and 21) using the revised Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale. The dual-diagnosed group exhibited more severe alcohol withdrawal, as indicated by higher total CIWA-Ar scores, at all time points than the alcohol-only group. The possibility that anxiety disorders and alcohol withdrawal share a common neurochemical basis and that the CIWA-Ar scale may be useful as a screening instrument for anxiety disorders in alcoholics is discussed.

摘要

相似文献

1
Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis.
Br J Addict. 1991 Jun;86(6):719-25. doi: 10.1111/j.1360-0443.1991.tb03098.x.
2
Assessment of the alcohol withdrawal syndrome--validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A).酒精戒断综合征的评估——翻译并修订后的酒精临床研究所戒断评估量表(CIWA-A)的有效性和可靠性。
Addiction. 1994 Oct;89(10):1287-92. doi: 10.1111/j.1360-0443.1994.tb03307.x.
3
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).酒精戒断评估:修订的临床研究所酒精戒断评估量表(CIWA-Ar)。
Br J Addict. 1989 Nov;84(11):1353-7. doi: 10.1111/j.1360-0443.1989.tb00737.x.
4
The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.在成人重症监护病房患者中,使用右美托咪定作为基于苯二氮䓬类药物治疗的辅助药物以降低酒精戒断谵妄的严重程度:一项系统评价。
JBI Database System Rev Implement Rep. 2015 Jan;13(1):224-52. doi: 10.11124/jbisrir-2015-1602.
5
Routine hospital alcohol detoxification practice compared to symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar).与使用客观戒断量表(CIWA-Ar)进行症状触发管理相比的常规医院酒精戒断实践。
Am J Addict. 2000 Spring;9(2):135-44. doi: 10.1080/10550490050173208.
6
Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake.奖赏渴望与戒断缓解渴望:对酒精摄入不同动机途径的评估。
Alcohol Alcohol. 2003 Jan-Feb;38(1):35-9. doi: 10.1093/alcalc/agg005.
7
Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.评估 CIWA-Ar 酒精戒断方案在综合医院环境中的合理使用。
Am J Drug Alcohol Abuse. 2018;44(4):418-425. doi: 10.1080/00952990.2017.1362418. Epub 2017 Oct 5.
8
Replacing the Clinical Institute Withdrawal Assessment-Alcohol revised with the modified Richmond Agitation and Sedation Scale for alcohol withdrawal to support management of alcohol withdrawal symptoms: potential impact on length of stay and complications.用改良的 Richmond 躁动与镇静评分量表替换临床研究所用戒断评估-酒精修订版,以支持对酒精戒断症状的管理:对住院时间和并发症的潜在影响。
CJEM. 2024 Jun;26(6):431-435. doi: 10.1007/s43678-024-00710-7. Epub 2024 May 26.
9
Psychopathology of alcoholics during withdrawal and early abstinence.酗酒者戒断及早期戒酒期间的精神病理学
Eur Psychiatry. 2000 Dec;15(8):483-8. doi: 10.1016/s0924-9338(00)00519-8.
10
Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.利用CIWA-Ar评估易患酒精戒断综合征患者中苯二氮䓬类药物的使用情况。
W V Med J. 2004 Jan-Feb;100(1):21-5.

引用本文的文献

1
Insights into Overlapping Brain Networks for Anxiety and Alcohol Use Disorders.对焦虑症和酒精使用障碍重叠脑网络的见解。
Curr Top Behav Neurosci. 2025 May 15. doi: 10.1007/7854_2025_592.
2
A systematic review of the economic evidence surrounding the management of alcohol withdrawal.对酒精戒断管理相关经济证据的系统评价。
Drug Alcohol Rev. 2025 May;44(4):990-1009. doi: 10.1111/dar.14053. Epub 2025 Apr 14.
3
IL-18 Signaling in the Rat Central Amygdala Is Disrupted in a Comorbid Model of Post-Traumatic Stress and Alcohol Use Disorder.
大鼠杏仁中央核中的 IL-18 信号转导在创伤后应激和酒精使用障碍共病模型中受到破坏。
Cells. 2023 Jul 27;12(15):1943. doi: 10.3390/cells12151943.
4
The Impact of Dietary Diversity, Lifestyle, and Blood Lipids on Carotid Atherosclerosis: A Cross-Sectional Study.膳食多样性、生活方式和血脂对颈动脉粥样硬化的影响:一项横断面研究。
Nutrients. 2022 Feb 15;14(4):815. doi: 10.3390/nu14040815.
5
Comorbidity of Alcoholism and Anxiety Disorders: The Role of Family Studies.酒精中毒与焦虑症的共病:家系研究的作用
Alcohol Health Res World. 1996;20(2):100-106.
6
TSPO polymorphism in individuals with alcohol use disorder: Association with cholesterol levels and withdrawal severity.酒精使用障碍个体中 TSPO 多态性:与胆固醇水平和戒断严重程度的关联。
Addict Biol. 2021 Jan;26(1):e12838. doi: 10.1111/adb.12838. Epub 2019 Nov 12.
7
Anxiety and alcohol use disorders: comorbidity and treatment considerations.焦虑症与酒精使用障碍:共病情况及治疗考量
Alcohol Res. 2012;34(4):414-31.
8
Startle response to unpredictable threat in comorbid panic disorder and alcohol dependence.伴发惊恐障碍和酒精依赖对不可预测威胁的惊跳反应。
Drug Alcohol Depend. 2013 Sep 1;132(1-2):216-22. doi: 10.1016/j.drugalcdep.2013.02.003. Epub 2013 Mar 7.
9
Anxiety and Substance Use Disorders: A Review.焦虑与物质使用障碍:综述
Psychiatr Times. 2008 Oct;25(10):19-23.
10
Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions.社交焦虑障碍与酒精使用障碍共病:来自国家酒精相关情况调查的研究。
Psychol Med. 2010 Jun;40(6):977-88. doi: 10.1017/S0033291709991231.